A new reality: GLP-1 as a personal experiment Many women describe their experience as: observing changes comparing cycles trying to interpret patterns Im basically figuring it out as I go. Mira survey participant GLP-1 medications are no longer just a metabolic conversation
Semaglutide is often chosen first if cost is a major barrier, if insurance covers it more reliably, or if someone is nervous about potentially stronger gastrointestinal side effects, and it has a long track record in both diabetes and chronic weight management, so clinicians may start there for a conservative yet effective approach, especially for modest weight loss goals, then consider switching to tirzepatide later if results plateau, side effects remain manageable, and coverage improves, and some practices even map out this stepwise plan during the very first visit
If you have been struggling to lose weight for your health and think semaglutide may be the answer, it could be a great option for you
For dose-volume conversions and frequency schedule, see the full CJC-1295 + Ipamorelin dosing protocol